v3.26.1
Equity Incentive Plan (Tables)
3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Schedule of Weighted Average Assumptions used for Stock Options

The following table presents the weighted-average assumptions used for stock options granted during the following periods:

 

   2026   2025 
  

Three Months Ended

March 31,

 
   2026   2025 
Grant date fair value  $1.91   $11.59 
Risk-free interest rate   3.8%   4.7%
Dividend yield   0.00%   0.00%
Expected life in years   6.0    5.9 
Expected volatility   135%   110%
Schedule of Stock Based Compensation Expense

 

   2026   2025 
  

Three Months Ended

March 31,

 
   2026   2025 
Research and development  $14,312   $7,620 
Selling, general and administrative   28,966    29,569 
Total  $43,278   $37,189 
Schedule of Stock Option Activity

A summary of the Company’s stock option activity (inclusive of the Inducement Award) is as follows:

 

  

Number of

Options

Outstanding

  

Weighted-

Average

Exercise

Price

  

Weighted-

Average

Remaining

Contractual

Term (in

Years)

 
Balance at December 31, 2025   20,477   $25.27    8.9 
Options granted   147,000    2.09    - 
Options exercised   -    -    - 
Options cancelled   -    -    - 
Balance at March 31, 2026   167,477   $4.93    9.6 
                
Options exercisable at March 31, 2026   14,022   $22.37    8.8